Search Results - "Walum, Joshua"
-
1
Th1 cytokines synergize to change gene expression and promote corticosteroid insensitivity in pediatric airway smooth muscle
Published in Respiratory research (16-05-2022)“…Corticosteroids remain a key therapy for treating children with asthma. Patients with severe asthma are insensitive, resistant, or refractory to…”
Get full text
Journal Article -
2
Chronic Allergen Challenge Induces Corticosteroid Insensitivity With Persistent Airway Remodeling and Type 2 Inflammation
Published in Frontiers in pharmacology (11-04-2022)“…Type 2-high severe asthma is described as a distinct endotype with Th2 inflammation, high eosinophil lung infiltration, impaired lung function, and reduced…”
Get full text
Journal Article -
3
Innate immune responses are increased in children with acute asthma exacerbation
Published in Pediatric allergy and immunology (01-06-2024)“…Background Little is known about the immune responses during acute asthma exacerbation. In this study, we examined immune responses in children following an…”
Get full text
Journal Article -
4
PRMT5 in T cells drives Th17 responses, mixed granulocytic inflammation and severe allergic airway inflammation1
Published in The Journal of immunology (1950) (14-03-2022)“…Severe asthma is characterized by steroid insensitivity and poor symptom control, and is responsible for the majority of asthma-related hospital costs…”
Get full text
Journal Article -
5
Corticosteroid insensitivity persists in the absence of STAT1 signaling in severe allergic airway inflammation
Published in American journal of physiology. Lung cellular and molecular physiology (01-12-2021)“…Corticosteroid insensitivity in asthma limits the ability to effectively manage severe asthma, which is characterized by persistent airway inflammation, airway…”
Get more information
Journal Article -
6
PRMT5 in T Cells Drives Th17 Responses, Mixed Granulocytic Inflammation, and Severe Allergic Airway Inflammation
Published in The Journal of immunology (1950) (01-04-2022)“…Severe asthma is characterized by steroid insensitivity and poor symptom control and is responsible for most asthma-related hospital costs. Therapeutic options…”
Get full text
Journal Article